UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005214
Receipt number R000006105
Scientific Title A randomized phase II study of a combination of docetaxel and bevacizumab versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with bevacizumab and platinum-based chemotherapy.
Date of disclosure of the study information 2011/03/08
Last modified on 2012/09/10 17:37:05

No. Disposal Last modified on Item of update
1 Insert 2011/03/08 10:44:40
2 Update 2011/03/09 09:05:06 Narrative objectives1
3 Update 2011/10/11 09:17:37 Recruitment status
4 Update 2012/01/04 18:50:19 Organization
Organization
Organization
Institute
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization1
Email1
5 Update 2012/09/10 17:37:05 Recruitment status